Income Statement - Cytek Biosciences, Inc. (CTKB)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 201.49 | 200.45 | 193.02 | 164.04 | 127.95 | 92.84 | 57.88 |
| Cost of revenue | 97.03 | 89.35 | 83.59 | 63.06 | 48.81 | 41.13 | 29.21 |
| Gross profit | 104.46 | 111.11 | 109.43 | 100.97 | 79.14 | 51.71 | 28.67 |
| Total operating expenses | 144.84 | 131.63 | 137.27 | 102.78 | 69.99 | 38.05 | 45.93 |
| Operating income | -40.38 | -20.52 | -27.85 | -1.80 | 9.16 | 13.66 | -17.26 |
| Non-operating income (net) | 10.54 | 14.82 | 12.14 | 3.06 | -3.22 | 0.77 | 0.96 |
| Income before tax | -29.84 | -5.70 | -15.71 | 1.26 | 5.94 | 14.43 | -16.29 |
| Income tax expense | 36.70 | 0.32 | -3.56 | -1.22 | 2.91 | -4.98 | 0.53 |
| Net income | -66.54 | -6.02 | -12.15 | 2.58 | 3.00 | 19.41 | -16.83 |
Show Quarterly Income Statement
Income Statement - Cytek Biosciences, Inc. (CTKB)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 44.14 | 62.14 | 52.29 | 45.60 | 41.46 | 57.48 | 51.50 | 46.62 | 44.86 | 58.23 | 48.00 | 49.69 | 37.09 | 48.34 | 40.48 | 40.16 | 35.06 | 38.89 | 34.38 | 30.41 | 24.27 | 30.62 | 25.10 | 19.14 | 17.99 |
| Cost of revenue | 22.88 | 29.26 | 24.74 | 21.74 | 21.30 | 23.82 | 22.50 | 21.18 | 21.85 | 25.19 | 20.82 | 21.53 | 16.05 | 18.96 | 13.62 | 15.60 | 14.89 | 15.26 | 13.10 | 10.66 | 9.79 | 11.17 | 9.48 | 10.87 | 9.61 |
| Gross profit | 21.25 | 32.89 | 27.55 | 23.87 | 20.16 | 33.65 | 29.01 | 25.44 | 23.01 | 33.05 | 27.18 | 28.16 | 21.04 | 29.37 | 26.86 | 24.56 | 20.18 | 23.64 | 21.28 | 19.75 | 14.49 | 19.45 | 15.62 | 8.27 | 8.38 |
| Total operating expenses | 39.72 | 38.48 | 36.74 | 34.49 | 35.13 | 30.67 | 33.25 | 33.96 | 33.75 | 33.19 | 33.60 | 37.29 | 33.20 | 29.29 | 25.50 | 25.45 | 22.53 | 22.32 | 18.38 | 15.93 | 13.35 | 11.57 | 8.91 | 8.49 | 9.09 |
| Operating income | -18.46 | -5.59 | -9.19 | -10.62 | -14.98 | 2.99 | -4.25 | -8.53 | -10.73 | -0.14 | -6.42 | -9.13 | -12.16 | 0.08 | 1.36 | -0.89 | -2.36 | 1.32 | 2.90 | 3.81 | 1.13 | 7.88 | 6.71 | -0.22 | -0.71 |
| Non-operating income (net) | 1.09 | 1.56 | 1.42 | 3.85 | 3.71 | 7.34 | 4.41 | 1.34 | 1.74 | 4.25 | 2.24 | 2.53 | 3.12 | 4.03 | 0.49 | -0.51 | -0.95 | -0.87 | -0.82 | -0.54 | -0.98 | 0.13 | 0.19 | 0.41 | 0.05 |
| Income before tax | -17.37 | -4.03 | -7.77 | -6.78 | -11.27 | 10.32 | 0.16 | -7.19 | -8.99 | 4.11 | -4.19 | -6.60 | -9.04 | 4.11 | 1.85 | -1.40 | -3.30 | 0.44 | 2.08 | 3.27 | 0.15 | 8.00 | 6.90 | 0.19 | -0.66 |
| Income tax expense | 1.49 | 40.05 | -2.29 | -1.19 | 0.14 | 0.68 | -0.78 | 3.25 | -2.82 | -1.39 | 2.27 | -2.21 | -2.23 | 0.40 | 0.22 | -0.70 | -1.15 | 1.61 | 0.66 | 0.60 | 0.05 | 2.40 | 0.36 | -7.92 | 0.18 |
| Net income | -18.87 | -44.08 | -5.48 | -5.58 | -11.40 | 9.64 | 0.94 | -10.43 | -6.17 | 5.50 | -6.46 | -4.39 | -6.81 | 3.53 | 1.67 | -0.60 | -2.02 | -1.19 | 1.42 | 2.67 | 0.10 | 5.60 | 6.54 | 8.11 | -0.84 |